C
Observers at the Workshop on Antiprogestins: Assessing the Science April 13–14, 1993

Duane Alexander, M.D.

National Institute of Child Health and Human Development

National Institutes of Health

Freedolph Anderson, M.D.

The Jones Institute for Reproductive Medicine Norfolk, Virginia

Wendy Baldwin, Ph.D.

National Institute of Child Health and Human Development

National Institutes of Health

Jose Barzelatto, M.D.

The Ford Foundation

Marie Bass

Bass & Howe

Washington, D.C.

Gabriel Bialy

National Institute of Child Health and Human Development

National Institutes of Health

James Bilstad, M.D.

Food and Drug Administration

Deeda Blair

Lasker Foundation

Kristof Chwalisz, M.D.

Schering AG

Berlin, Germany

Francine Coeytaux, Ph.D.

Los Angeles, California

C. Edgar Cook, Ph.D.

Research Triangle Institute

Philip Corfman, M.D.

Food and Drug Administration

Horacio Croxatto, M.D.

Pontificia

Universidad Catolica de Chile

Robert B. Dickson, Ph.D.

Lombardi Cancer Research Center Georgetown University

Erlinda Etucbanas, M.D.

Berlex Laboratories Richmond, California



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 278
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda C Observers at the Workshop on Antiprogestins: Assessing the Science April 13–14, 1993 Duane Alexander, M.D. National Institute of Child Health and Human Development National Institutes of Health Freedolph Anderson, M.D. The Jones Institute for Reproductive Medicine Norfolk, Virginia Wendy Baldwin, Ph.D. National Institute of Child Health and Human Development National Institutes of Health Jose Barzelatto, M.D. The Ford Foundation Marie Bass Bass & Howe Washington, D.C. Gabriel Bialy National Institute of Child Health and Human Development National Institutes of Health James Bilstad, M.D. Food and Drug Administration Deeda Blair Lasker Foundation Kristof Chwalisz, M.D. Schering AG Berlin, Germany Francine Coeytaux, Ph.D. Los Angeles, California C. Edgar Cook, Ph.D. Research Triangle Institute Philip Corfman, M.D. Food and Drug Administration Horacio Croxatto, M.D. Pontificia Universidad Catolica de Chile Robert B. Dickson, Ph.D. Lombardi Cancer Research Center Georgetown University Erlinda Etucbanas, M.D. Berlex Laboratories Richmond, California

OCR for page 278
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda Robin Foldesy, Ph.D. Gynopharma, Inc. Somerville, New Jersey Marilynn Frederiksen, M.D. Northwestern University Henry Gabelnick, Ph.D. CONRAD Arlington, Virginia George Gaines National Institute of Child Health and Human Development National Institutes of Health Dr. Dominique Garrel Centre de Recherche Hôtel-Dieu de Montréal Mark Graham II, M.D. Lineberger Cancer Center University of North Carolina Forrest Greenslade, Ph.D. IPAS Carrboro, North Carolina Steven Grunberg, M.D. Comprehensive Cancer Center University of Southern California Florence Haseltine, M.D., Ph.D. National Institute of Child Health and Human Development National Institutes of Health R. Brian Heap, Ph.D., Sc.D., F.R.S. AFRC—Institute of Animal Physiology and Genetics Research Cambridge, England Jennifer Jackman Feminist Majority Washington, D.C. Harold Kaminetzky, M.D. American College of Obstetricians and Gynecologists Paul Lammers, M.D. Organon West Orange, New Jersey John Lamont, M.D. McMaster University Roderick Mackenzie Gynopharma, Inc. Somerville, New Jersey Carolyn Makinson Andrew Mellon Foundation Donald McDonnell, Ph.D. Ligand Pharmaceuticals, Inc. La Jolla, California Irwin Merkatz, M.D. Albert Einstein School of Medicine Ruth Merkatz, Ph.D. Food and Drug Administration Ana Murphy, M.D. Emory University Mary Pendergast Food and Drug Administration Audrey Phillips, Ph.D. R.W. Johnson Pharmaceutical Research Institute Raritan, New Jersey Michael Policar, M.D., M.P.H. Planned Parenthood Federation of America New York, New York William Regelson, M.D. Medical College of Virginia

OCR for page 278
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda Seymour Romney, M.D. Albert Einstein School of Medicine Sarah Samuels, Dr.P.H. Henry J. Kaiser Family Foundation Professor Gilbert Schiason Hopital de Bicêtre Paris, France Ekkehard Schillinger, M.D. Schering AG Berlin, Germany Sheldon Segal, Ph.D. Population Council New York, New York Solomon Sobel, M.D. Food and Drug Administration Jeff Spieler Agency for International Development Washington, D.C. Catherine Stika, M.D. Northwestern University Irene Stith-Coleman, Ph.D. Congressional Research Service Washington, D.C. Pamela Stratton, M.D. National Institute of Child Health and Human Development National Institutes of Health Rosemarie Thau, Ph.D. Population Council New York, New York Helena von Hertzen, D.D.S., M.D. World Health Organization Geneva, Switzerland Charles Watlington, M.D., Ph.D. Virginia Commonwealth University Beverly Winikoff, M.D., M.P.H. Population Council New York, New York Susan Wood, Ph.D. Congressional Caucus for Women's Issues Washington, D.C. IOM STAFF Kenneth Shine, M.D. President Enriqueta Bond, Ph.D. Executive Officer Michael Stoto, Ph.D. Director, Division of Health Promotion and Disease Prevention Ruth Bulger, Ph.D. Director, Division of Health Sciences Policy Molla Donaldson, M.S. Study Director Sarah Brown, M.P.H. Senior Program Officer Karen Foote Commission on Behavioral and Social Sciences and Education (National Research Council) Linda DePugh Anna Mastroianni, J.D. Terri Barba Helen Rogers